OutSourcingPharma RSS http://www.outsourcing-pharma.com/ Breaking News on Outsourcing Pharma en-gb ℗ & © 2008 Decision News Media fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) Wed, 03 Dec 2008 07:01:39 +0100 eZ Components Feed 1.1 (http://ezcomponents.org/docs/tutorials/Feed) http://www.rssboard.org/rss-specification 60 http://www.outsourcing-pharma.com/var/plain_site/storage/images/rss-feeds/outsourcingpharma-rss/1264034-1-eng-GB/OutSourcingPharma-RSS.gif OutSourcingPharma RSS http://www.outsourcing-pharma.com/ Successful FDA inspection for NextPharma http://www.outsourcing-pharma.com/Clinical-Development/Successful-FDA-inspection-for-NextPharma <div class="introduction"> <p> </p> <p> NextPharma’s facility in Waltrop, Germany has undergone a successful inspection by the US Food and Drug Administration (FDA). </p> </div> Clinical Development http://www.outsourcing-pharma.com/Clinical-Development/Successful-FDA-inspection-for-NextPharma Tue, 02 Dec 2008 11:00:00 +0100 inVentive signs up to help GeneraMedix’ epoprostenol http://www.outsourcing-pharma.com/Commercial-Services/inVentive-signs-up-to-help-GeneraMedix-epoprostenol <div class="introduction"> <p> </p> <p> inVentive Health has been contracted to provide marketing and branding services for fellow US based generic injectables developer GeneraMedix, specifically focusing on the latter’s epoprostenol hypertension treatment. </p> <p> </p> </div> Gareth Macdonald Commercial Services http://www.outsourcing-pharma.com/Commercial-Services/inVentive-signs-up-to-help-GeneraMedix-epoprostenol Tue, 02 Dec 2008 11:00:00 +0100 WuXi ends US biologics manufacture; focus on testing http://www.outsourcing-pharma.com/Contract-Manufacturing/WuXi-ends-US-biologics-manufacture-focus-on-testing <div class="introduction"> <p> </p> <p> WuXi PharmaTech is to discontinue its US biologics manufacturing operations as it attempts to cut costs, with 100 employees due to lose their jobs. </p> </div> Nick Taylor Contract Manufacturing http://www.outsourcing-pharma.com/Contract-Manufacturing/WuXi-ends-US-biologics-manufacture-focus-on-testing Tue, 02 Dec 2008 11:00:00 +0100 Cell culture shortage predicted http://www.outsourcing-pharma.com/Contract-Manufacturing/Cell-culture-shortage-predicted <div class="introduction"> <p> </p> <p> A report has predicted that contract mammalian cell culture manufacturers are likely to struggle to cope with increased demand in coming years. </p> </div> Contract Manufacturing http://www.outsourcing-pharma.com/Contract-Manufacturing/Cell-culture-shortage-predicted Tue, 02 Dec 2008 11:00:00 +0100 Quintiles gets bigger in cancer with TMD purchase http://www.outsourcing-pharma.com/Preclinical-Research/Quintiles-gets-bigger-in-cancer-with-TMD-purchase <div class="introduction"> <p> </p> <p> Quintiles Transnational has boosted its array of services for companies developing cancer drugs via the purchase of Illinois, US-based firm Targeted Molecular Diagnostics. </p> </div> Phil Taylor Preclinical Research http://www.outsourcing-pharma.com/Preclinical-Research/Quintiles-gets-bigger-in-cancer-with-TMD-purchase Tue, 02 Dec 2008 11:00:00 +0100 VenturiOne v3 launched for batch analysis http://www.outsourcing-pharma.com/Preclinical-Research/VenturiOne-v3-launched-for-batch-analysis <div class="introduction"> <p> </p> <p> Applied Cytometry (AC) hopes its VenturiOne v3 software, which is capable of processing 400 files in under 10 seconds, will win over drug developers looking to expedite large-scale laboratory analysis. </p> <p> </p> </div> Preclinical Research http://www.outsourcing-pharma.com/Preclinical-Research/VenturiOne-v3-launched-for-batch-analysis Tue, 02 Dec 2008 11:00:00 +0100 Althea manufacturing drug with novel delivery tech http://www.outsourcing-pharma.com/Contract-Manufacturing/Althea-manufacturing-drug-with-novel-delivery-tech <div class="introduction"> <p> </p> <p> Althea Technologies has signed a contract manufacturing deal, under which it will produce Bio-Path’s lead novel therapeutic drug for upcoming clinical trials. </p> </div> Nick Taylor Contract Manufacturing http://www.outsourcing-pharma.com/Contract-Manufacturing/Althea-manufacturing-drug-with-novel-delivery-tech Mon, 01 Dec 2008 11:00:00 +0100 Mumbai attacks could hurt India’s outsourcing sector http://www.outsourcing-pharma.com/Contract-Manufacturing/Mumbai-attacks-could-hurt-India-s-outsourcing-sector <div class="introduction"> <p> </p> <p> Postponement of this year’s CPhI and P-MEC India events for “security reasons” may be only the first impact of last week’s Mumbai terror attacks on the country’s outsourcing industry, according to PwC’s life sciences head Sujay Shetty. </p> <p> </p> </div> Gareth Macdonald Contract Manufacturing http://www.outsourcing-pharma.com/Contract-Manufacturing/Mumbai-attacks-could-hurt-India-s-outsourcing-sector Mon, 01 Dec 2008 11:00:00 +0100 Open-source EDC software gaining ground http://www.outsourcing-pharma.com/Clinical-Development/Open-source-EDC-software-gaining-ground <div class="introduction"> <p> </p> <p> An open-source software suit for electronic data capture (EDC) in clinical trials – OpenClinica - is starting to see a dramatic rise in usage, according to its developer Akaza Research. </p> </div> Phil Taylor Clinical Development http://www.outsourcing-pharma.com/Clinical-Development/Open-source-EDC-software-gaining-ground Thu, 27 Nov 2008 11:00:00 +0100 Encorium publishes delayed financials http://www.outsourcing-pharma.com/Clinical-Development/Encorium-publishes-delayed-financials <div class="introduction"> <p> </p> <p> Troubled contract research organisation Encorium Group finally published its delayed financial results yesterday, posting a net loss of $3.9m, three times the year-earlier loss. </p> </div> Phil Taylor Clinical Development http://www.outsourcing-pharma.com/Clinical-Development/Encorium-publishes-delayed-financials Thu, 27 Nov 2008 11:00:00 +0100